NDC 68025-097 – Relexxii
Methylphenidate Hydrochloride 36 mg/1 · Tablet, Extended Release · Oral
Product NDC68025-097
Product details
- Brand name
- Relexxii
- Generic name
- methylphenidate hydrochloride
- Labeler
- Vertical Pharmaceuticals, LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA216117
- Marketed since
- June 23, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Central Nervous System Stimulant
Active ingredients
- Methylphenidate Hydrochloride 36 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 68025-097-10 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-097-10) | Nov 1, 2023 |
| 68025-097-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-097-30) | Aug 12, 2024 |
Other Relexxii products
- 68025-084 Methylphenidate Hydrochloride 72 mg/1 · Tablet, Extended Release · Vertical Pharmaceuticals, LLC
- 68025-088 Methylphenidate Hydrochloride 45 mg/1 · Tablet, Extended Release · Vertical Pharmaceuticals, LLC
- 68025-089 Methylphenidate Hydrochloride 63 mg/1 · Tablet, Extended Release · Vertical Pharmaceuticals, LLC
- 68025-095 Methylphenidate Hydrochloride 18 mg/1 · Tablet, Extended Release · Vertical Pharmaceuticals, LLC
- 68025-096 Methylphenidate Hydrochloride 27 mg/1 · Tablet, Extended Release · Vertical Pharmaceuticals, LLC
- 68025-098 Methylphenidate Hydrochloride 54 mg/1 · Tablet, Extended Release · Vertical Pharmaceuticals, LLC